Savara (SVRA) Common Equity (2010 - 2026)
Savara's (SVRA) quarterly Common Equity came in at $176.0 million in Q1 2026, up 19.07% year-on-year from $147.8 million in Q1 2025, and up 202443.68% on a QoQ basis from -$87000.0 in Q4 2025.
Savara (SVRA) Common Equity (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Common Equity data on file, last reported at $176.0 million in Q1 2026.
- On a quarterly basis, Common Equity rose 19.07% year-over-year to $176.0 million in Q1 2026; TTM through Mar 2026 was $176.0 million, a 19.07% increase from a year earlier, with the FY2025 full-year figure at -$87000.0, up 88.4% from the prior year.
- Common Equity for Q1 2026 stood at $176.0 million, up from -$87000.0 in the prior quarter.
- Over the last five years, Common Equity for SVRA reached as high as $199.3 million in Q3 2024 and fell as low as -$750000.0 in Q4 2024.
- Historically, Common Equity has averaged $107.5 million across 5 years, with a median of $120.5 million in 2025.
- Across the five-year window, Common Equity soared 2155460.0% in 2022 and sank 100.53% in 2024, its largest moves.
- Year by year, Common Equity stood at $107.8 million in 2022, then soared by 30.24% to $140.4 million in 2023, then tumbled by 100.53% to -$750000.0 in 2024, then soared by 88.4% to -$87000.0 in 2025, then jumped by 202443.68% to $176.0 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $176.0 million in Q1 2026, -$87000.0 in Q4 2025, and -$155000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 176.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 176.04 Mn |
| Dec 31, 2025 | -87,000.00 |
| Sep 30, 2025 | -155,000.00 |
| Jun 30, 2025 | 120.48 Mn |
| Mar 31, 2025 | 147.85 Mn |
| Dec 31, 2024 | -750,000.00 |
| Sep 30, 2024 | 199.35 Mn |
| Jun 30, 2024 | 101.73 Mn |
| Mar 31, 2024 | 121.86 Mn |
| Dec 31, 2023 | 140.37 Mn |
| Sep 30, 2023 | 146.54 Mn |
| Jun 30, 2023 | 87.72 Mn |
| Mar 31, 2023 | 98.26 Mn |
| Dec 31, 2022 | 107.78 Mn |
| Sep 30, 2022 | 116.51 Mn |
| Jun 30, 2022 | 127.04 Mn |
| Mar 31, 2022 | 136.48 Mn |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 155.23 Mn |
| Jun 30, 2021 | 165.38 Mn |